Medicine, Pulmonary, Allergy, and Critical Care Medicine
-
-
Administers Grant
-
19-Gauge needle aspiration of thoracic lymph nodes
-
A 24-week, double-blind, randomized, parallel-group study evaluating the efficacy and safety of oral nintedanib co-administered with oral sildenafil, compared to treatment with nintedanib alone, in patients with idiopathic pulmonary fibrosis (IPF)
-
A 52-week, double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of Nintedanib, 150 mg twice daily, in patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
-
A Case-Control Study to Verify Diagnostic Performance of AminoIndex¿ Technology
-
A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United States
-
A Multi-center, randomized, placebo controlled, ascending dose Phase I study designed to asses the safety, tolerability, and pharmacokinetics of PTI-428 in subjects with Cystic Fibrosis
-
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease
-
A Phase 2, Open-Label, Extension Study to Evaluate the Long-
Term Safety and Efficacy of Ubenimex in Patients with
Pulmonary Arterial Hypertension (WHO Group 1)
-
A Phase II Study of Inhaled Carbon Monoxide for the Treatment of ARDS
-
A Pilot Study of Transitioning from Parenteral Prostacyclins to Selexipag
-
A Randomized Phase II Clinical Trial of L-Citrulline to Improve Asthma Control in Obese Late Onset Asthma
-
A Systems Biology Approach to HIV-associated Neurocognitive Impairment: Role of Drug Abuse and Neuroinflammation
-
A double-blind, placebo-controlled, multi-centre, clinical trial to investigate the efficacy and safety of therapy with inhaled colistimethate sodium in the treatment of subjects with non-CF bronchiectasis chronically infected with P. aeruginosa
-
A linkage study in familial pulmonary fibrosis
-
A multi-center, randomized, double-blind, placebo controlled, parallel group study to compare cessation versus continuation of long-term mepolizumab treatment in patients with severe eosinophilic asthma (201810)
-
A multi-centre, open label, single arm, 32-week treatment study in subjects with severe eosinophilic asthma not optimally controlled with current omalizumab treatment who are switched from omalizumab to mepolizumab 100 mg subcutaneous-the OSMO study
-
A multicentre, randomized, parallel group, Phase 3 safety extension study to evaluate the safety and tolerability of benralizumab (MEDI-563) in asthmatic adults and adolescents on inhaled corticosteroid plus long-acting ss2 agonist (BORA)
-
A phase 3 extension study of ataluren (PTC124) in patients with nonsense mutation cystic fibrosis. Protocol: PTC124-GD-021e-CF
-
A phase III clinical trial to demonstrate the effectiveness and safety of Liposomal Cyclosporine A (L-CsA) inhalation solution delivered via the PARI Investigational eFlow device plus standard of care v. standard of care of BOS in double lung transpl
-
A phase III clinical trial to demonstrate the effectiveness and safety of Liposomal Cyclosporine A (L-CsA) inhalation solution delivered via the PARI Investigational eFlow device plus standard of care v. standard of care of BOS in single lung transpl
-
A pivotal multi-center, randomized, controlled, single-blinded study comparing the silver nitrate-coated indwelling pleural catheter (SNCIPC) to the uncoated PleurX pleural catheter for the management of symptomatic, recurrent, malignant pleural effu
-
A randomized, double-blind, chronic dosing placebo-controlled, parallel group, multicenter, Phase III study to evaluate the efficacy and safety of 2 doses of benralizumab (MEDI-563) in patients with moderate to very severe COPD with a history of COPD
-
A randomized, double-blind, placebo-controlled, parallel-group, Proof-of-Concept (PoC) study to assess the efficacy, safety and tolerability of SAR440340, in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD)
-
AC-065B302 Select: Radomized double blind placebo controlled parallel group group sequential adaptive Phase 3 study with open label extention period to assess efficacy and safety of Selexipag
-
AN-EPI3333 RESULT
-
APD 811-301 - Phase III
-
APD-811-303
-
ARDSNet Option 4
-
ARDSNet Option 5 extension
-
ARINA-1
-
AZ CHINOOK D3250C00059 A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group,
Placebo-controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics
-
AZ D5180C00018 DESTINATION: A multicentre double blind randomized placebo controlled parallel group phase 3 safety extension study to evaluate safety & tolerability of Tezepelumab
-
AZ Natron D3254C00001: A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 24-week Phase 3 Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizum
-
AZLI in lung transplant recipients
-
Acute Lung Injury - Mechanisms And Therapy
-
Acute Lung Injury And Repair
-
Acute Lung Injury Mechanisms And Therapy
-
AdheRence to Inhaled Corticosteroids in Asthma (ARICA)
-
All In One: Multicenter prospective trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoracic approaches for the biopsy of peripheral pulmonary nodules
-
American Lung Association (ALA) Novel Digital Diary (ANDDI) Trial
-
American Lung Association Airways Clinical Research Centers Network
-
An Open-Label Extension study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease
-
Analytics 4 Life PHDEV Secondary
-
Arrestin selectivity for GPCRs in airway smooth muscle
-
Asthma BMI Baseline Study (ABBS)
-
Award for a Mental Health Coordinator
-
BCX7353-204 An open label study to evaluate the long-term safety of daily oral BCS7353 in subjects with Type I and II hereditary angioedema
-
BCX7353-302:Phase 3 randomized doubleblind placebo controlled parallel group study evaluate efficacy&safety of 2-dose levels BCS7353 as oral treatment for prevention of attacks w/hereditary angioedema
-
BDX-CD-003 Altitude: A multicenter randomized controlled trial prospectively evaluating the clnical utility of Nodify XL2 Proteomic Classifier in incendentally low to moderate risk lung nodules
-
BEAT- An Open label extension of BPS-314d-MR-PAH-303
-
BI 1199.248 INBUILD-ON An open label extension trial of the long term safety of nintedanib in patients with progressive fibrosing interstitial lung disease.
-
BPS-314d-MR-PAH-302. BEAT: A Multicenter, Doubled-Blind, Randomized, Placebo-Controlled, Phase 3 Study To Assess The Efficacy And Safety of Oral B.
-
BROADWAY: Broncho-Adventitial Delivery of Paclitaxel To Extend Airway Patency in Malignant Airway Obstruction Patients
-
BT-L-CsA-302-DLT BOSTON-3
-
Biological determinants of environmental airway injury
-
Biology Of Nitric Oxide Derived From Airway Epithelium
-
Blood flow and tissue oxygenation using optical coherence tomography
-
Blood-SCAN feasibility Phase 3
-
CC011-19
-
CF Lung Transplant Transition LLC Phase 2 Program Extension Post NACFC October 2018 through May 30, 2019
-
CHEST ADVANCED CLINICAL TRAINING PROGRAM-Idiopathic Pulmonary Fibrosis
-
CHEST ADVANCED CLINICAL TRAINING PROGRAM-Idiopathic Pulmonary Fibrosis
-
COPD Genetic Epidemiology Program - Clinical Center Site Agreement
-
CPR-05394 ANET Electrosurgery Applicator Pilot Evaluation Study
-
CSL Behring IgPro20_4004
-
CTOT Ancillary Studies Fund
-
CTOT Ancillary Studies Fund Carry Forward BAL
-
CXCL10/CXCR3 regulation of ozone-induced epithelial permeability
-
Care Center Network Charter Agreement
-
Cell-Free DNA for Diagnosis of Malignancy, Genetic Mutations and Prognosis in Lung Cancer Related Pleural Effusions
-
Cell-free DNA in the Blood and Lung Allograft Fluid: Understanding Association with Acute Rejection in Lung Transplant Recipients
-
Cellular Mechanisms that Regulate Protein Nitrosylation
-
Center For Extrapolation Modeling
-
Center For Extrapolation Modeling: Microtoxicology/Microdo
-
Center For Extrapolation Modelling
-
Center for Environmental Genomics
-
Characterization of CMV-specific T cell responses in immunocompromised hosts
-
Chronic Lung Allograft Dysfunction
-
Clara Cell Secretion and Oxidant Lung Pollutants
-
Clinical Calibration of a Digital, Low Cost Spirometry Device
-
Clinical Center Core
-
Clinical Centers For A Clinical Network For The Treatment
-
Clinical Centers For Lung Volume Reduction Surgery For Emp
-
Clinical Centers for a Clinical Research Network for the Treatment of Acute Lung Injury and Adult Respiratory Distress Syndrome
-
Clinical and Molecular Epidemiology of Acute Kidney Injury After Lung Transplant
-
Clinical features of lung transplant recipients with prolonged survival (>15 years) from the ISHLT registry
-
Clinical indicators for early bone loss in Common Variable Immunodeficiency
-
Club Cells and CCSP in the pathogenesis of CLAD/spatial transcriptomics
-
Coagulation regulates inflammation in acute lung injury
-
Complexa PRIME - CXA-10-301
-
Complexa Prime Open Label extention
-
Cook Medical Education Course - Human Fresh Tissue Lab Education Program Agreement
-
Cystic Fibrosis Lung Transplant Consortium
-
Cystic Fibrosis Lung Transplant Consortium
-
Cystic Fibrosis Lung Transplant Transition - Regional Dissemination Network
-
D3250C00037 A multicenter, open-label, safety extension study with benralizumab (MEDI-563) for asthmatic adults on inhaled corticosteroid plus long-acting ss2 agonist (MELTEMI)
-
D5180C00009 SOURCE A multicentre randomized double blind placebo controlled Phase 3 study to evaluate the efficacy and safety of Tezepelumab
-
DS1040-B-U107: Phase 1B, Assess the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of DS-1040B when added to standard of care in subjects with submassive pulmonary embolism
-
Diesel-induced Alterations of Influenza Infectivity
-
Diesel-induced Alterations of Influenza Infectivity
-
Disciplinary Training Program In Lung Disease
-
Display Memoryrapolation Modeling: Microtoxicology/Micro
-
Do changes in bronchoalveolar fluid cells correlate with immune polarization, acute rejection, lung injury, or chronic lung allograft dysfunction (CLAD) after lung transplantation? CTOT
-
Duke - UNC Cystic Fibrosis Tissue Procurement Partnership
-
Duke - UNC Cystic Fibrosis Tissue Procurement Partnership
-
Duke CFF PACE Application
-
EAST 2: Elaluation of the Archimedes System for Transparenchymal Nodule Access 2
-
ECP Management of BOS
-
EFC1580 BOREAS: A randomized double blind placebo controlled parallel group 52wk study to assess the efficacy, safety, and tolerability of Dupilumab in patients with moderate to severe COPD w/Type 2
-
Ec-Sod In Airway And Pulmonary Vascular Biology
-
Edrf, Nitrosthiols And Platelet Function
-
Edrf, Nitrosthiols, And Platelet Function
-
Effect Of Chronic Exposure To Ozone Or Nitrogen Dioxide
-
Effects of Teleflex Catheter on Ventilator Mechanics
-
Effects of glycopryrrolate/formoterol (Bevespi) on ventilation and gas exchange abnormalities in COPD assessed by 129Xe MRI
-
Efficacy and Safety of VX-659-102 Combination Therapy in Subjects iwth Cystic Fibrosis who are heterozygous for F508del Mutation & minimal function mutation
-
Electron Microscope
-
Epithelial-mesenchymal crosstalk in lung fibrosis and alveolar homeostasis
-
Evaluate Efficacy and Safety of CC-90001 in Subjects with Idiopathic Pulmonary Fibrosis
-
Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension in Heart FAilure with Preserved Ejection Fraction (HFpEF)
-
Evaluation of the host immune response and viral molecular phenotype in lung transplant recipients with PTLD
-
Extracellular Matrix, Innate Immunity, and Ozone-induced Airways Disease
-
Fetal Lung Biochemistry & 3d Microanatomy
-
Fetal Lung Biochemistry & Microanatomy
-
Fetal Lung Biochemistry And 3-Dimensional Microanatomy
-
Fetal Lung Biochemistry And 3d Microanatomy
-
Fetal Lung Biochemistry And Microanatomy
-
GA39831: An observational study to assess disease relevant outcomes using home monitoring devices in patients with idiopathic pulmonary fibrosis
-
GLPG1690-CL-304 A Phase 3 randomized double blind parallel group, placebo controlled multicenter study to evaluate efficacy and safety of 2 doses of GLPG1690 in addition to local standard of care
-
GS-US-218-1797
-
GSK Study CTT116855
-
GSNO Reductase, S-Nitrosothiols, and Asthma
-
Genentech Xenon MRI IPF Study
-
Genetic Regulation of Lung Transplant Outcomes
-
Genetic regulation of O3-induced inflammation in humans
-
Genetics of Acute Rejection and Chronic Lung Allograft Dysfunction
-
HABP/VABP
-
HAE Outcome Study. An observational, non-interventional, study of patients with Hereditary Angioedema in the United States and Canada.
-
HELP Study Extension: An open-label study to evaluate the long-term safety and efficacy of DX-2930 for prevention against acute attacks of hereditary angioedema (HAE)
-
Hand-held advanced functional imager for assessing local tissue oxygenation
-
Hyaluronan in Acute Rejection and Chronic Allograft Dysfunction after Lung Transplantation - CTOT Ancillary
-
Hyaluronan in Acute Rejection and Chronic Lung Allograft Dysfunction after Human Lung Transplantation
-
Hypo- And Hyperbaric Research Facilities
-
Hypo- And Hyperbaric Research Support Facilities
-
I2PP2A and Asthma
-
IMPALA MOL-PAP-002 A randomised double blind placebo controlled multicentre clinical trial of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis patients
-
IMR PSA: Wendy Curry
-
IPA - Hongmei Zhu
-
IPA - Hongmei Zhu
-
IPA - John Patterson
-
IPA - Joseph Herbert
-
IPA - Kathryn Stempel
-
IPA - Linhua Song
-
IPA - Nisha Srivastava
-
IPA - Youwei Chen
-
IPA Agreement - Julia Walker
-
IPA- Hongmei Zhu
-
Identifying treatment outcomes and early predictors of failure in 600 hospitalized patients with acute exacerbation of COPD treated with non-invasive ventilation
-
Idiopathic Pulmonary Fibrosis Prespective Outcomes (IPF-PRO) Registry
-
IgPro20_1001 Phase I, Comparison of 2 infusion devisces with respet to Pharmacokinetics, safety, and tolerability of Hizentra: an investigational wearable infusor and Crono S-PID-50 Infusion Pump
-
Immune Profiles to Better Understand Chronic Allograft Dysfunction and Successful Long-term Clinical Outcomes after Human Lung Transplantation
-
Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes
-
Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration
-
Impact of patient specific factors on CF lung transplant outcomes
-
Impaired release of antiadhesive ATP from stored RBCs: a novel transfusion lesion
-
Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH)
-
Improving decision making for patients with prolonged mechanical ventilation
-
Incyte INCB39110-214
-
Influence of anaerobic RBC storage on RBC ATP export
-
Informing Decisions in Chronic Critical Illness: An RCT
-
Innate Immune Mechanisms in Non-infectious Lung Inflammation
-
Innate Immune Response to Environmental Endotoxin
-
Innate immune responses in obliterative bronchiolitis
-
Integrated Toxicology
-
Interdisciplinary Training Program In Lung Disease
-
Interdisciplinary Training Program In Lung Disease
-
Interdisciplinary Training Program In Lung Disease
-
Interdisciplinary Training Program In Lung Disease
-
Interdisciplinary Training Program in Lung Disease
-
Interdisciplinary Training Program in Lung Disease
-
Interdisciplinary Training program in lung disease
-
International Research Scientist Development Award
-
Intervention Study In overweight patients with COPD (INSIGHT COPD) trial
-
Intervention Study In overweight patients with COPD (INSIGHT COPD) trial
-
Invasion of the Alveolar Epithelium by Pseudomonas
-
LOTT Option 1
-
LOTT Option II
-
LOTT Option III
-
LOTT Option IV Core
-
LTI-01-2001 A Phase 2 randomized placebo controlled double blind dose ranging study evaluating LTI-01 in patients with infected non-draining pleural effusions
-
Long Term Follow up of the Lung Transplant Outcomes Group Cohort
-
Long-term Oxygen Treatment Trial (LOTT) - Regional Clinical Centers (RCCs)
-
Longitudinal assessment of CMV and BK virus immunity in renal transplant patients
-
Lung Injury Protection by Coagulation Blockade
-
Lung Tissue Gene Expression Profiling in Chronic Lung Allograft Dysfunction-CTOT
-
Lung Transplantation in Chronic HCV Infection with Post Transplant EPCLUSA Treatment
-
Lymphocyte Exhaustion Markers in Malignant Pleural Effusions of Lung Cancer
-
Lymphocyte exhaustion markers in malignanc pleural effusions of lung cancer
-
MEA117106: Mepolizumab v. Placebo as add-on treatment for frequently exacerbating COPD patients
-
MIF-Based Therapies in Cigarette Smoke-Related COPD and Pneumonia
-
MIF-based Therapies for Severe Lung Disease
-
Magnetically directed single cell transcriptome analysis in HIV latency
-
Mallinckrodt Educational Workshop
-
Mallinckrodt MNK14344100: Phase 4 Multicenter randomized double blind placebo controlled pilot study to assess the efficacy and safety of H.P. Acthar Gel in subjects with Pulmonary Sarcoidosis
-
Master Agreement - Phase I/Ii Clinical Evaluation Of Biol.
-
Matrix Metalloproteinase-19 as a Mediator of Airway Fibrosis in Obese Allergic Asthma
-
Measuring/Improving Quality of Life in Acute Lung Injury
-
Mechanisms And Treatment Of Phosgene Poisoning
-
Mechanisms of lung injury following autologous BMT
-
Mechanisms that Direct Airway Remodeling in Obese Asthma
-
Mechanisms that Direct Airway Remodeling in Obese Asthma
-
Medtronic Education Course 2019
-
Methods for the amplification and identification of airway stem cells
-
Mitochondrial Redox Perturbations in Obese Allergic Asthma
-
Mitochondrial biogenesis in sepsis-induced organ dysfunction
-
Mitochondrial quality control and alveolar damage resolution after acute lung injury
-
Mobile Mindfulness to Improve Psychological Distress after Critical Illness
-
Modulation of Asthma by GSNO-based Therapies
-
Modulation of NO with Pulmonary Gene Transfer
-
Morphometric Studies Of The Effects Of Air Pollutants On
-
Multicenter, open-label, single-group study to assess the tolerability and the safety of the TRANSITion from inhaled treprostinil to oral selexipag in adult patients with pulmonary arterial hypertension.
-
NAVIGATE
-
ND-L02-s0201-005 Phase 2 randomized double blind placebo controlled study to evaluate safety, tolerability, biological activity, and PK of ND-L02-s0201 in subjects with IPF
-
NO hemoglobin interactions in the pulmonary vasculature
-
National Biological Sample and Data Repository for PAH
-
Needs and triggers: improving intensive care unit-based palliative care delivery
-
Nhlbi Shared Research Facility
-
Nitric oxide and mitochondrial biogenesis in sepsis
-
Novartis VAY736: A subject, investigator, and sponsor blinded randomized placebo controlled multicenter study to investigate VAY736 in patients with idiopathic pulmonary fibrosis
-
Novel 4Dx functional lung imaging in diagnosis and follow up of CLAD
-
Novel Dialysis-Like Therapeutics in Sepsis-induced Shock and Organ Failure
-
Novel role for CD163 in ozone induced alterations of pulmonary immunity
-
Novel role for CD163 in ozone induced alterations of pulmonary immunity
-
Obesity, Inflammation, and Lung Injury after Lung Transplantation
-
Open-label extension study to evaluate the long-term safety and tolerability of dupilumab in patients with asthma who participated in a previous dupilumab asthma clinical study
-
Opsummit Historical Users cohort study (OrPHeUS)
-
Optimizing a self-directed mobile copying skills training intervention for improving cardiorespiratory failure survivors
-
Optimizing a self-directed mobile mindfulness intervention for improving cardiorespiratory failure survivors' psychological distress
-
Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma
-
Oxidative tissue damage mitigation after exposure to HBO2 using FDA approved anti-epileptic drugs (AEDs)
-
Ozone Dosimetry Using Radioactive And Stable Isotopes
-
Ozone Primes Pulmonary Innate Immunity
-
PCplanner: operationalizing needs-focused palliative care for older adults in intensive
-
PREPARE - PeRson EmPoweRed Asthma RElief Study
-
PSA for Mona Malik
-
PSA for Jessica Shier
-
PTC 124-GD-021-CF
-
PTI 428-06: A phase 2 multicenter randomized double blind placebo controlled study to assess the safety tolerability pharmacokinetics and effect of PTI-428 in subjects with cystic fibrosis
-
PTI 801-01
-
Pathogenesis of Neuroinflammation and Neurocognitive Impairment In HIV-infected Young Adult Cannabis Users
-
Percepta R-1 Registry
-
Phase 3b, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor (TEZ/IVA) in an Orkambi-experienced Population
-
Phase III of Treprostinil in patients with PH-COPD
-
Pilot: Zinc Acetate to Treat Chronic Refractory Cough (ZICO)
-
Pneumonia in the Immunocompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens(Pickup)
-
Prediction of Functional Outcomes from Chronic Critical Illness
-
Predictors and Outcomes of Post-transplant lymphoproliferative disorder in lung transplant recipients
-
Program Project: Acute Lung Injury And Repair
-
Project 2: Regulation of Mitochondrial Quality Control by Heme Oxygenase-1 System in Sepsis
-
Promedior PRM-151
-
Proof of Concept Treatment Interventions in a Rodent Model of the Rare Disease Bronchiolitis Obliterans
-
Proteomics of flavorings-induced airway disease
-
Pseudomonas Invasion and the Role of Caveolin-2
-
Pulmonary Fibrosis Foundation Biomarker and/or Patient Registry Protocols
-
Quotation for review of asthma clinic database records
-
RADPH - Building a Repository of Phase Signals for Algorithm Development from Subjects with Pulmonary Hypertension.
-
RVT-1201 A Phase 2a, Double-Blind Placebo-Controlled Multicenter Study to Assess the Safety tolerability pharmacokinetics and pharmacodynamic effects of RVT-1201 in Patients with PAH
-
Red Blood Cell S-nitrosothiols and Oxygenation
-
Redifining Therapy in Early COPD (RETHINC) Trial
-
Redifining Therapy in Early COPD (RETHINC) Trial (Industry Sponsored)
-
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/Pneumonia
-
Redox Signalling By Nitric Oxide In Skeletal Muscle
-
Redox Signalling by Nitric Oxide in Skeletal Muscle
-
Redox signaling by nitric oxide in skeletal muscle
-
Reevaluation Of Systemic Early neuromuscular blockade
-
Regulation and function of EC-SOD
-
Regulation of Cardiac Adrenergic Function by S-nitrosylation
-
Regulation of Lung Fibrosis by Alternatively Activated Macrophages and Arginase-1
-
Regulation of NF-Kappa B by nitric oxide in the lung
-
Regulation of Pulmonary Fibrosis by CXCR3
-
Regulation of mitochondrial biogenesis by heme oxygenase-1
-
Regulation of ryanodine receptor by nitrogen oxides
-
Remimazolam (CNS7056) Patients Undergoing Bronchoscopy
-
Respiratory Compromise & Unplanned Intubations
-
Respivant RVT1601-CC-04 SCENIC: Randomized double blind placebo controlled dose ranging efficacy and safety study with inhaled RVT-1601 for the treatment of persistent cough in patients with IPF
-
Restoration and Function of S-nitrosothiol in Stored Blood
-
Restrospective Study of Outcomes of Patients with WHO Groups 1 and 3 Pulmonary Hypertension Treated with High-Dose Inhaled Treprostinil
-
RofLumilast or Azithromycin to preveNt COPD Exacerbations (RELIANCE)
-
Role of CXC chemokines at the innate-adaptive interface of alloimmune lung injury
-
Role of Resident Monocytes in the Pathogenesis of Pulmonary Arterial Hypertension
-
Role of S-nitrosothiols on Akt1 signaling and pneumonia resolution
-
Role of TLR4 in Environmental Asthma
-
Ryanodine Receptors in Bronchoconstriction
-
S-nitrosothiol-regulated pathways in acute lung injury
-
S-nitrosothiols, NF-KappaB and Inflammation in Acute Lung Injury
-
SAILS
-
SANOFI EFC-13579 (SAR231893)
-
SPRAY-CB: A Sham controlled prospective randomized trial of the RejuvenAir system for the treatment of moderate to severe chronic obstructive pulmonary disease with chronic bronchitis
-
Sepsis-induced Red Cell Dysfunction (SiRD)
-
Sepsis-induced Red Cell Dysfunction (SiRD)
-
Silicato-Iron Complex And Interstitial Lung Injury
-
Silicato-Iron Complex And Interstititial Lung Injury
-
Sites Of Oxidants And Antioxidants In Lung Cells
-
Sites Of Oxidants And Antoixidants In Lung Cells
-
Small molecule screen to enhance epithelial repair
-
Spiration Valve System (SVS) Post Market Registry Study for Severe Emphysema P180007/PAS002
-
Stem Cells in Airway Repair
-
Stem Cells to Enhance Bronchiolar Reparative Capacity
-
Structure and Function of S-nitrosohemoglobin
-
Surfactant Protein-A regulation of eosinophil apoptosis in asthma
-
T cell function in asthma depends on a novel signaling pathway
-
TDE-HF-302 Open-label extension study of oral Treprostinil in subjects with Pulmonary Hypertension associated wiht Heart Failure with Preserved Ejection Fraction- A long-term follow-up to TDE-HF-301
-
TLR4-MEDIATED EPIGENETIC AND SENESCENCE MECHANISMS IN EMPHYSEMA
-
TRACE: Selexipag ACT-293987, AC-065A404 A multicenter double-blind placebo controlled Phase 4 study in patients with pulmonary arterial hypertension to assess the effect of selexipag
-
Targeting Health Care Provider (HCP) Burnout Crisis during COVID-19
-
The HELP Study
-
The Silicator-Iron Complex And Interstitial Lung Injury
-
The effect of household air pollution on the health outcomes of infants in Botswana
-
The interface of B and T cells in Transplant
-
The role of Pdgfra+ fibroblasts in lung fibrosis and alveolar homeostasis
-
The role of SP-A in Mp-induced exacerbations during allergic airway disease
-
The role of SP-A in Mp-induced exacerbations during allergic airway disease.
-
The study of new therapies for sarcoidosis
-
Toxic And Therapeutic Effects Of Hyperbaric Oxygen
-
Toxic And Therapeutic Effects Of Oxygen
-
Toxic And Therapeutic Effects Of Oxygen
-
Toxic and Therapeutic Effects of Oxygen
-
Trauma, conflict, and racial disparities in the intensive care unit
-
Treatment For Patients With Stage Iii & Iv Cancer
-
Treatment For Patients With Stage Iii And Iv Cancer
-
Treatment For Patients With Stage Iii And Iv Head And
-
Trial of Roflumilast in Asthma Management (TRIM)
-
US - Base, observational, drug registry of Opsumit (macitentan) new users in clinical practice (OPUS Registry)
-
US CTEPH Registry
-
United States Pulmonary Hypertension Scientific Registry
-
VX17-659-105 Open Label A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic
Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
-
VX18-445-113 A Phase 3 open label study evaluating the long term safety of VX-445 combination therapy in subjects with cystic fibrosis
-
Vyaire Educational Workshop
-
same
-
same
-
same
-
same